M. Kulyk & Associates, LLC

Position in NVO — Novo Nordisk A S

CIK 1842370 DECATUR, GA

Position in NVO

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$4,477,596

-$1,119,833 QoQ

Shares Held

93,400

-38.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.95%

of 13F equity value

Holder Rank

#235

of 1,348 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

M. Kulyk & Associates, LLC holds $37,765,981 across 8 Drug Manufacturers - General names. NVO ranks #4 (11.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	94,863	$12,189,895
2	LLY	ELI LILLY & Co	7,945	$9,529,472
3	GILD	Gilead Sciences, Inc.	74,859	$9,457,686
4	NVO	Novo Nordisk A S This page	93,400	$4,477,596
5	ABBV	AbbVie Inc.	3,846	$967,807
6	JNJ	Johnson & Johnson	1,941	$492,955
7	NVS	Novartis AG	2,439	$382,240
8	AMGN	Amgen Inc	741	$268,330

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,477,596	93,400	-38.7%	Shares	Sole	2026-08-07
2026-03-31	$5,597,429	152,311	+0.0%	Shares	Sole	2026-05-06
2025-12-31	$7,745,971	152,240	+17.1%	Shares	Sole	2026-01-08
2025-09-30	$7,214,199	130,009	+68.1%	Shares	Sole	2025-11-10
2025-06-30	$5,336,764	77,322	+17.3%	Shares	Sole	2025-08-07
2025-03-31	$4,575,887	65,897	+1970.9%	Shares	Sole	2025-05-06
2024-12-31	$273,715	3,182	+3.9%	Shares	Sole	2025-02-07
2024-09-30	$364,711	3,063	-33.9%	Shares	Sole	2024-11-07
2024-06-30	$661,742	4,636	-16.3%	Shares	Sole	2024-08-05
2024-03-31	$710,822	5,536	-5.5%	Shares	Sole	2024-05-09
2023-12-31	$606,217	5,860	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.